Azathioprine in the treatment of systemic lupus erythematosus. A three-year prospective study
- 1 September 1984
- journal article
- Published by Springer Nature in Clinical Rheumatology
- Vol. 3 (3) , 285-291
- https://doi.org/10.1007/bf02032333
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Prognostic value of anti-dsDNA in SLE.Annals of the Rheumatic Diseases, 1982
- Anti‐dsdna and complement profiles as prognostic guides in systemic lupus erythematosusArthritis & Rheumatism, 1979
- Significance Of Persisting Serologic Abnormalities In SLEArthritis & Rheumatism, 1976
- On survivorship in the nephritis of systemic lupus erythematosusArthritis & Rheumatism, 1975
- Influence of cyclophosphamide and other immunosuppressive drugs on immune disorders and neoplasia in NZB/NZW MICEArthritis & Rheumatism, 1975
- Therapeutic studies in NZB/W MICEArthritis & Rheumatism, 1975
- A double‐blind controlled trial comparing cyclophosphamide, azathioprine and placebo in the treatment of lupus glomerulonephritisArthritis & Rheumatism, 1974
- Further observations on the treatment of lupus nephritis with prednisone and combined prednisone and azathioprineArthritis & Rheumatism, 1974
- Comparison of Azathioprine, Prednisone, and Heparin Alone or Combined in Treating Lupus nephritisNephron, 1973
- Therapeutic studies in NZB/W mice. II. Relative efficacy of azathioprine, cyclophosphamide and methylprednisoloneArthritis & Rheumatism, 1972